[P2–054]: BRAIN DELIVERY OF AN AMYLOID‐β OLIGOMER (AβO)‐TARGETING PEPTIDE‐THERAPEUTIC BY A NOVEL BLOOD‐BRAIN BARRIER (BBB)‐CROSSING DOMAIN ANTIBODY. (1st July 2017)